Terms: = Bone cancer AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Treatment
19 results:
1. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract] [Full Text] [Related]
2. Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies.
R P; Shanmugam G; Rakshit S; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155026. PubMed ID: 38118219
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
[TBL] [Abstract] [Full Text] [Related]
4. Function and return to sports after proximal humeral replacement in patients with primary bone sarcoma.
Ellerbrock M; Theil C; Gosheger G; Deventer N; Klingebiel S; Rickert C; Schneider KN
J Orthop Traumatol; 2022 Dec; 23(1):59. PubMed ID: 36571630
[TBL] [Abstract] [Full Text] [Related]
5. Large Oncosome-Loaded VAPA Promotes bone-Tropic Metastasis of Hepatocellular Carcinoma Via Formation of Osteoclastic Pre-Metastatic Niche.
Zhang S; Liao X; Chen S; Qian W; Li M; Xu Y; Yang M; Li X; Mo S; Tang M; Wu X; Hu Y; Li Z; Yu R; Abudourousuli A; Song L; Li J
Adv Sci (Weinh); 2022 Nov; 9(31):e2201974. PubMed ID: 36169100
[TBL] [Abstract] [Full Text] [Related]
6. 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.
Herber CB; Yuan C; Chang A; Wang JC; Cohen I; Leitman DC
Mol Med; 2022 Apr; 28(1):44. PubMed ID: 35468719
[TBL] [Abstract] [Full Text] [Related]
7. Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots.
Collins CJ; Yi F; Dayuha R; Whiteaker JR; Ochs HD; Freeman A; Su HC; Paulovich AG; Segundo GRS; Torgerson T; Hahn SH
Front Immunol; 2020; 11():464. PubMed ID: 32296420
[TBL] [Abstract] [Full Text] [Related]
8. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Burroughs LM; Petrovic A; Brazauskas R; Liu X; Griffith LM; Ochs HD; Bleesing JJ; Edwards S; Dvorak CC; Chaudhury S; Prockop SE; Quinones R; Goldman FD; Quigg TC; Chandrakasan S; Smith AR; Parikh S; Dávila Saldaña BJ; Thakar MS; Phelan R; Shenoy S; Forbes LR; Martinez C; Chellapandian D; Shereck E; Miller HK; Kapoor N; Barnum JL; Chong H; Shyr DC; Chen K; Abu-Arja R; Shah AJ; Weinacht KG; Moore TB; Joshi A; DeSantes KB; Gillio AP; Cuvelier GDE; Keller MD; Rozmus J; Torgerson T; Pulsipher MA; Haddad E; Sullivan KE; Logan BR; Kohn DB; Puck JM; Notarangelo LD; Pai SY; Rawlings DJ; Cowan MJ
Blood; 2020 Jun; 135(23):2094-2105. PubMed ID: 32268350
[TBL] [Abstract] [Full Text] [Related]
9. Tizanidine hydrochloride exhibits a cytotoxic effect on osteosarcoma cells through the PI3K/AKT signaling pathway.
Xing XW; Sun YF; Zhao J; Pan ZX; Jiang WX
J Int Med Res; 2019 Aug; 47(8):3792-3802. PubMed ID: 31179788
[TBL] [Abstract] [Full Text] [Related]
10. A Novel Peptide from Vespa ducalis Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways.
Wu R; Li D; Tang Q; Wang W; Xie G; Dou P
Biol Pharm Bull; 2018; 41(4):458-464. PubMed ID: 29607921
[TBL] [Abstract] [Full Text] [Related]
11. Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).
Habl G; Straube C; Schiller K; Duma MN; Oechsner M; Kessel KA; Eiber M; Schwaiger M; Kübler H; Gschwend JE; Combs SE
BMC Cancer; 2017 May; 17(1):361. PubMed ID: 28532400
[TBL] [Abstract] [Full Text] [Related]
12. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Anderson PM; Bielack SS; Gorlick RG; Skubitz K; Daw NC; Herzog CE; Monge OR; Lassaletta A; Boldrini E; Pápai Z; Rubino J; Pathiraja K; Hille DA; Ayers M; Yao SL; Nebozhyn M; Lu B; Mauro D
Pediatr Blood Cancer; 2016 Oct; 63(10):1761-70. PubMed ID: 27362300
[TBL] [Abstract] [Full Text] [Related]
13. Primary Immune Deficiency treatment Consortium (PIDTC) report.
Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Pai SY; Ballard B; Bauer SC; Bleesing JJ; Boyle M; Brower A; Buckley RH; van der Burg M; Burroughs LM; Candotti F; Cant AJ; Chatila T; Cunningham-Rundles C; Dinauer MC; Dvorak CC; Filipovich AH; Fleisher TA; Bobby Gaspar H; Gungor T; Haddad E; Hovermale E; Huang F; Hurley A; Hurley M; Iyengar S; Kang EM; Logan BR; Long-Boyle JR; Malech HL; McGhee SA; Modell F; Modell V; Ochs HD; O'Reilly RJ; Parkman R; Rawlings DJ; Routes JM; Shearer WT; Small TN; Smith H; Sullivan KE; Szabolcs P; Thrasher A; Torgerson TR; Veys P; Weinberg K; Zuniga-Pflucker JC;
J Allergy Clin Immunol; 2014 Feb; 133(2):335-47. PubMed ID: 24139498
[TBL] [Abstract] [Full Text] [Related]
14. The endocannabinoid system and cancer: therapeutic implication.
Guindon J; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1447-63. PubMed ID: 21410463
[TBL] [Abstract] [Full Text] [Related]
15. Unrelated bone marrow transplantation with a reduced toxicity myeloablative conditioning regimen in Wiskott-Aldrich syndrome.
Kang HJ; Shin HY; Ko SH; Park JA; Kim EK; Rhim JW; Kim JG; Ahn HS
J Korean Med Sci; 2008 Feb; 23(1):146-8. PubMed ID: 18303217
[TBL] [Abstract] [Full Text] [Related]
16. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.
Pai SY; DeMartiis D; Forino C; Cavagnini S; Lanfranchi A; Giliani S; Moratto D; Mazza C; Porta F; Imberti L; Notarangelo LD; Mazzolari E
Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426
[TBL] [Abstract] [Full Text] [Related]
17. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
[TBL] [Abstract] [Full Text] [Related]
18. Long-term survival following non-Hodgkin's lymphoma arising in Wiskott-Aldrich syndrome.
Gilson D; Taylor RE
Clin Oncol (R Coll Radiol); 1999; 11(4):283-5. PubMed ID: 10473730
[TBL] [Abstract] [Full Text] [Related]
19. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.
Mullen CA; Anderson KD; Blaese RM
Blood; 1993 Nov; 82(10):2961-6. PubMed ID: 8219187
[TBL] [Abstract] [Full Text] [Related]
